Texas Cancer Institute Adopts Kallisio’s Patient-Specific Stentra™ Oral Immobilization Solution
Texas Cancer Institute in Austin, Texas has adopted the patient-specific Stentra™ solution from Kallisio as standard-of-care for head and neck cancer radiation therapy following a successful pilot program.
BALTIMORE–(BUSINESS WIRE)– #cancer–Kallisio announces TCI in Austin, Texas has adopted patient-specific Stentra™ for improved head and neck cancer radiation therapy.